Electroencephalography (EEG) is one of the most accessible and cost-effective methods for measuring human brain activity. While EEG is routinely used in clinical practice for epilepsy and sleep disorders, its broader application in neuropsychiatry and neurodegenerative disease remains limited. This likely reflects not only overlapping pathophysiological mechanisms and symptom profiles across disorders, but also methodological challenges in EEG research, including heterogeneous preprocessing procedures, limited reproducibility, and the lack of standardized frameworks for validating biomarkers across cohorts and research sites. This thesis explores computational approaches to facilitate the development and translation of EEG-based biomarkers into clinical applications. It focuses on three interconnected challenges, including model-informed biomarker development and validation, EEG preprocessing and quality control, and the integration of these components within a shared, standardized infrastructure that supports reproducible analyses across datasets, cohorts, and clinical settings. Using the theory of critical brain dynamics, in which the brain operates in or near a critical state, balancing its excitation and inhibition, we develop a method for quantifying the excitation/inhibition ratio from EEG across narrow frequency bands (Chapter 1). We show that this ratio reflects deviations from near-critical network dynamics associated with changes in excitation/inhibition balance. To investigate its biological relevance in disease, we apply the method in a preclinical mouse model of Alzheimer's disease, where it detects shifts toward excitatory dominance and supercritical dynamics in hippocampal and cortical recordings (Chapter 2). Because reliable estimation of EEG-based biomarkers depends on high-quality signal preprocessing, we develop a deep-learning model for artifact detection (Chapter 3) and integrate it into an AI-assisted signal viewer for guided annotation of resting-state EEG (Chapter 4). The results suggest that AI is not yet sufficiently mature to replace expert review but can support and guide manual annotation while facilitating the creating of large, well-annotated datasets for future model development. Finally, we present a proof-of-concept cloud platform designed to support reproducible, collaborative EEG biomarker research and clinical translation. The platform creates a shared environment for end-to-end EEG analysis, integrating EEG visualization, preprocessing, quality control, phenotypic profiling, biomarker extraction, and interactive clinician-oriented reporting. The platform is evaluated in both academic and clinical settings, demonstrating its ability to scale EEG preprocessing and analysis while supporting transparent and reproducible workflows. By supporting data reuse, version-controlled processing pipelines, and model-validated algorithms, such infrastructure may help accelerate the translation of quantitative EEG into clinial practice. Taken together, this thesis contributes methodological and technological advances that support the development, validation, and clinical implementation of EEG-based biomarkers.